9 September 2010

Cyan

Company Details

Address:
Buckingway Business Park , Swavesey , Cambridge CB24 4UQ
Telephone:
01954 234 400
Fax:
01954 234 405
Email:
sales@cyantechnology.com
Website:
www.cyantechnology-ir.com

Commentary

Semiconductor company specialising in the development of low powered, configurable microcontroller chips

Executives

Chairman:
John Read (1% holding)
Chief Executive:
Kenn Lamb (5.8% holding)
Non-Exec Director:
Simon Smith (.5% holding)

Main Shareholders

Peter Lobbenberg: 15.1%

Rensburg Sheppards: 6.1%

Barnard Nominees: 5.9%

Allianz Insurance: 5.1%

Standard Life: 4.8%

Advisers

Nominated Adviser:
Cenkos Securities
Nominated Broker:
Cenkos Securities
Solicitors:
Dechert
Auditors:
Deloitte
Registrar:
Capita Registrars

Accounts Information

Entry on AIM:
7/12/2005
Issue Price:
22.0p
Interim Results:
Sep
Final Results:
Mar
Year End:
Dec
Accounts Due:
Jun
Int div payment:
n/a
Fin div payment:
n/a
Int net div per share:
nil
Fin net div per share:
nil

Financial History

  2009 2008
Turnover: £0.09m £0.14m
Pre-tax profit: £ (3.13m) £ (4.46m)
EPS: (0.5) p (1.7) p

Associated Articles

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Popular News

Latest News

Futura hails product progress 08/09/2010

Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.

Tags: AIM , Deals & contracts , Fundraisings , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Futura Medical

Dana details bid defence 08/09/2010

Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.

Tags: Commodities , Full list , Growth Stocks

Sector: Oil & Gas Producers

Companies: Dana Petroleum

Abcam 'cautious' after strong growth 07/09/2010

Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.

Tags: AIM , Cash , Dividends , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Abcam

More News

Sectors

Vitesse Media Events